Fingolimod Capsule
Product Images NDC 82249-385

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 82249-385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Civicascript Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fingolimod-graph-1 (Fingolimod Graph 1)

A line graph showing the percentage of patients with three-month confirmed progression over time (up to 720 days). Two groups are compared: Fingolimod capsule 0.5 mg treatment group with a solid line and placebo group with a dashed line. The graph indicates lower progression in the Fingolimod group (18%) compared to the placebo group (24%) at the end of the period.*

FDA Label Image

Fingolimod-hcl-structure. (Fingolimod HCl Structure)

Chemical structure diagram of Fingolimod, showing its molecular structure with hydroxyl groups, an amine group, and a chloride ion.*

FDA Label Image

Fingolimod Label (Fingolimod Label)

Fingolimod Capsules 0.5 mg packaging label from CivicaScript LLC. The label indicates 30 capsules per bottle with instructions to dispense with enclosed medication guide. It includes dosage information and storage instructions, a barcode, QR code, and manufacturer details for Alembic Laboratories Ltd., Mumbai, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.